GHS Classification Guidance for the Japanese Government
GHS Classification Guidance for the Japanese Government GHS Classification Guidance for the Japanese Government
* Unless a description that definitely denies hazards or recognizes extremely low hazards is available in List 1, the determination of “Not classified” should be performed carefully. If there is any question, a given substance should rather be classified in “Classification not possible” due to insufficient information for judgment. * When an affected organ can be identified, indicate the applicable category along with the affected organ in parentheses for “GHS classification.” When such an organ cannot be identified, put “systemic toxicity” in parentheses. (Example entry:Category 1 (liver, kidney, blood), or Category 1 (systemic toxicity)) * In a case where a substance can be classified in Category 1 (respiratory organs) or Category 2 (respiratory organs), it shall be not classified in Category 3 (respiratory tract irritation). * When the same substance is classified into different categories depending on affected organs, indicate the category for each of the affected organs. (Example entry: Category 1 (liver, kidney), Category 2 (blood), Category 3 (respiratory tract irritation)) * As for substances of which data are available only for a mixture (provided mixed or diluted with solvents without toxicity), their GHS classification as pure substances are performed by estimating from concentrations appropriately, and the estimation processes are to be described as a ground for classification. B) Regarding classification procedure 1) Substances meeting [Decision criteria 1a] or [Decision criteria 1b] below are placed in Category 1. [Decision criteria 1a]: Substances for which evidence of inducing toxic effects in humans are (Notes) available in List 1. a) Effects on organs that are obviously known to be secondary effects shall be excluded from description. Judgement by experts shall be sought for where necessary about whether the effects are secondary or not. When such a judgment is difficult, all organs affected shall be cited. b) Effects on respiratory system by site of contact are included here, and are placed in Category 1 (pneumoconiosis, etc.). However, such effects by site of contact other than respiratory tract, for example, irritation/inflammation reaction in digestive system in a case of oral administration of a corrosive/irritant, are considered to be subsumed under other toxicity items such as skin corrosion, and are not classified in specific target organ toxicity. c) When only minimal symptoms (slight fever, languor, etc.) are reported, the substance is placed in “Not classified”. 176
d) All organs described as affected in List 1 shall be indicated. However, when organs listed in multiple assessment documents based on the same type of tests are not the same, indicate the commonly listed organs. When a toxic symptom alone is described and the affected organ cannot be identified, put “systemic toxicity” instead. When the target organ is identified, fundamentally, a description of toxic symptom is not required. e) When the affected organ can be identified, indicate the applicable category along with the affected organ in parentheses in “GHS classification”. When the affected organ cannot be identified, put “systemic toxicity” in parentheses. [Decision criteria 1b]: Animal tests meeting all of conditions below a) Any animal species is applicable. b) Exposure amount is identified and toxic symptom is induced within the guidance value range of Category 1 c) The test is described in List 1 or an OECD TG test in List 2, is according to GLP, and has received some degree of approval (by multiple reviewers) (Notes) a) As for toxic effects, read the UN GHS second revised edition and the following documents carefully. b) Effects on organs that are obviously known to be secondary effects shall be excluded from description. Judgement by experts shall be sought for where necessary as to whether the effects are secondary or not. c) Effects on respiratory system by site of contact are included here and are placed in Category 1 (pneumoconiosis, etc.). However, such effects by site of contact other than respiratory tract, for example, irritation/inflammation reaction in digestive system in a case of oral administration of a corrosive/irritant, are considered to be subsumed under other toxicity items such as skin corrosion and are not classified in specific target organ toxicity. d) When only minimal symptoms (slight fever, etc.) are reported, the substance is placed in “Not classified”. e) All organs described as affected in List 1 shall be indicated. However, when organs listed in multiple assessment documents based on the same type of tests are not the same, indicate the commonly listed organs. When a toxic symptom alone is described and the affected organ cannot be identified, put “systemic toxicity” instead. When the target organ is identified, fundamentally, a description of toxic symptom is not required. f) As for conversion of exposure amount, the technical guideline for acute toxicity shall be used (except for the criteria for dealing with animal species difference). 177
- Page 130 and 131: B) Classification criteria in GHS (
- Page 132 and 133: (4)Guidance for classification and
- Page 134 and 135: G) Strategy of testing and evaluati
- Page 136 and 137: 2c Structure activity Skin corrosiv
- Page 138 and 139: done in parallel. This stage should
- Page 140 and 141: criteria given below:” a) If ther
- Page 142 and 143: [Decision Criteria 1]: In the cases
- Page 144 and 145: substance shall be classified in Ca
- Page 146 and 147: The classification is based on any
- Page 148 and 149: 7) Data from various kinds of tests
- Page 150 and 151: Table 3-8 Test data as the basis of
- Page 152 and 153: Category 1B. Mutagens classified a
- Page 154 and 155: c)Exceptionally, strong positive re
- Page 156 and 157: 3-2-6 Carcinogenicity (1)Definition
- Page 158 and 159: The principles of GHS classificatio
- Page 160 and 161: B) Substance for which GHS classifi
- Page 162 and 163: metabolic system, a cautious invest
- Page 164 and 165: hazard warning for pregnant women a
- Page 166 and 167: OECD414 Prenatal development toxici
- Page 168 and 169: D) Decision logic and classificatio
- Page 170 and 171: e considered to be sufficient. (Sub
- Page 172 and 173: No. Test guideline Limit dose 414 P
- Page 174 and 175: 3-2-8 Specific Target Organ Toxicit
- Page 176 and 177: specifically for these effects as d
- Page 178 and 179: existing MSDSs. A literature search
- Page 182 and 183: g) When the affected organ can be i
- Page 184 and 185: 3-2-9 Specific Target Organ Toxicit
- Page 186 and 187: Table 3-16: Guidance value ranges f
- Page 188 and 189: (c) Any consistent and significant
- Page 190 and 191: has received some degree of approva
- Page 192 and 193: As for the classification of specif
- Page 194 and 195: formed in the mouth, which then may
- Page 196 and 197: The classification criteria refer t
- Page 198 and 199: 194
- Page 200 and 201: (1)Sources for test data for Hazard
- Page 202 and 203: List 2: Useful information sources
- Page 204 and 205: 3-3)EU classification When classif
- Page 206 and 207: 4-2 Classification of Hazardous to
- Page 208 and 209: water solubility, and which are not
- Page 210 and 211: Tests shall be conducted by using f
- Page 212 and 213: e categorized based on chronic aqua
- Page 214 and 215: endpoint. When it is not clear whet
- Page 216 and 217: that the relevant information sourc
- Page 218 and 219: 214
- Page 220 and 221: R39 Danger of very serious irrevers
- Page 222: R52 Harmful to aquatic organisms. R
d) All organs described as affected in List 1 shall be indicated. However, when organs<br />
listed in multiple assessment documents based on <strong>the</strong> same type of tests are not <strong>the</strong><br />
same, indicate <strong>the</strong> commonly listed organs. When a toxic symptom alone is described<br />
and <strong>the</strong> affected organ cannot be identified, put “systemic toxicity” instead. When <strong>the</strong><br />
target organ is identified, fundamentally, a description of toxic symptom is not required.<br />
e) When <strong>the</strong> affected organ can be identified, indicate <strong>the</strong> applicable category along with<br />
<strong>the</strong> affected organ in paren<strong>the</strong>ses in “<strong>GHS</strong> classification”. When <strong>the</strong> affected organ<br />
cannot be identified, put “systemic toxicity” in paren<strong>the</strong>ses.<br />
[Decision criteria 1b]: Animal tests meeting all of conditions below<br />
a) Any animal species is applicable.<br />
b) Exposure amount is identified and toxic symptom is induced within <strong>the</strong> guidance value<br />
range of Category 1<br />
c) The test is described in List 1 or an OECD TG test in List 2, is according to GLP, and<br />
has received some degree of approval (by multiple reviewers)<br />
(Notes)<br />
a) As <strong>for</strong> toxic effects, read <strong>the</strong> UN <strong>GHS</strong> second revised edition and <strong>the</strong> following<br />
documents carefully.<br />
b) Effects on organs that are obviously known to be secondary effects shall be excluded<br />
from description. Judgement by experts shall be sought <strong>for</strong> where necessary as to<br />
whe<strong>the</strong>r <strong>the</strong> effects are secondary or not.<br />
c) Effects on respiratory system by site of contact are included here and are placed in<br />
Category 1 (pneumoconiosis, etc.). However, such effects by site of contact o<strong>the</strong>r than<br />
respiratory tract, <strong>for</strong> example, irritation/inflammation reaction in digestive system in a<br />
case of oral administration of a corrosive/irritant, are considered to be subsumed under<br />
o<strong>the</strong>r toxicity items such as skin corrosion and are not classified in specific target organ<br />
toxicity.<br />
d) When only minimal symptoms (slight fever, etc.) are reported, <strong>the</strong> substance is placed<br />
in “Not classified”.<br />
e) All organs described as affected in List 1 shall be indicated. However, when organs<br />
listed in multiple assessment documents based on <strong>the</strong> same type of tests are not <strong>the</strong><br />
same, indicate <strong>the</strong> commonly listed organs. When a toxic symptom alone is described<br />
and <strong>the</strong> affected organ cannot be identified, put “systemic toxicity” instead. When <strong>the</strong><br />
target organ is identified, fundamentally, a description of toxic symptom is not required.<br />
f) As <strong>for</strong> conversion of exposure amount, <strong>the</strong> technical guideline <strong>for</strong> acute toxicity shall be<br />
used (except <strong>for</strong> <strong>the</strong> criteria <strong>for</strong> dealing with animal species difference).<br />
177